StockData
Bruker Corp logo

Bruker Corp (BRKRP) stock

BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$445.11+5.48 (+1.25%)

Close on Nov 17, 2026Market cap $9.52BP/E –Yield –

Earnings

Bruker's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 11, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$874.00M
+1.6% on a year earlier
non-GAAP diluted EPS, Q3 FY2026
$0.56
$0.45 a year earlier
Latest guidance
Reaffirmed
Nov 4, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Bruker's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 11, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$874.00M+1.6%-$0.81$0.56Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open$838.50M+5.2%-$0.41$0.49Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$823.40M+2.7%$0.02$0.31Release
Q4 FY2025ended Dec 31, 2025Feb 12, 2026before the open$977.20M-0.2%$0.10$0.59Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025before the open$860.50M-0.5%-$0.41$0.45Release
Q2 FY2025ended Jun 30, 2025Aug 4, 2025before the open$797.40M-0.4%$0.05$0.32Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open$801.40M+11.0%$0.11$0.47Release
Q4 FY2024ended Dec 31, 2024Feb 13, 2025before the open$979.60M+14.6%$0.09$0.76Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024before the open$864.40M+16.4%$0.27$0.60Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$800.70M+17.4%$0.05$0.52Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$721.70M+5.3%$0.35$0.53Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Bruker's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Organic revenue growthnon-GAAPFY2026+1% – +2%+1% – +2%ReaffirmedNov 4, 2026
revenuesGAAPFY2026$3.52B – $3.56B–NewNov 4, 2026
revenuesFY2026$3.57B – $3.60B–NewFeb 12, 2026
RevenuesFY2026$3.54B – $3.57B$3.57B – $3.60BLoweredAug 4, 2026
non-GAAP EPSnon-GAAPFY2026$2.10 – $2.15$2.10 – $2.15ReaffirmedNov 4, 2026
Non-GAAP EPSnon-GAAPFY2026$2.10 – $2.15$2.10 – $2.15ReaffirmedAug 4, 2026

Guidance vs results

The last range Bruker gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025non-GAAP EPS$1.85 – $1.90$1.83Σ4QBelow range
FY2025Revenue$3.41B – $3.44B$3.44BΣ4QWithin range
FY2025Revenue growth+1% – +2%+2.08%Σ4QAbove range

Guidance history

Every forecast Bruker put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026non-GAAP EPSFY2026$2.10 – $2.15Reaffirmed
Nov 4, 2026Organic revenue growthFY2026+1% – +2%Reaffirmed
Nov 4, 2026revenuesFY2026$3.52B – $3.56BNew
Aug 4, 2026Non-GAAP EPSFY2026$2.10 – $2.15Reaffirmed
Aug 4, 2026RevenuesFY2026$3.54B – $3.57BLowered
May 6, 2026non-GAAP EPSFY2026$2.10 – $2.15New
May 6, 2026revenuesFY2026$3.57B – $3.60BNew
Feb 12, 2026non-GAAP EPSFY2026$2.10 – $2.15New
Feb 12, 2026Organic revenue growthFY2026+1% – +2%New
Feb 12, 2026revenuesFY2026$3.57B – $3.60BNew
Nov 3, 2025non-GAAP EPSFY2025$1.85 – $1.90New
Nov 3, 2025reported revenue growthFY2025+1% – +2%New
Nov 3, 2025Organic revenue declineFY2025-5% – -4%New
Nov 3, 2025M&A revenue growth contributionFY2025+3.5%Raised
Nov 3, 2025Foreign currency translation revenue tailwindFY2025+2.5%Lowered
Nov 3, 2025revenuesFY2025$3.41B – $3.44BNew
Aug 4, 2025non-GAAP EPSFY2025$1.95 – $2.05Lowered
Aug 4, 2025revenuesFY2025$3.43B – $3.50BNew
May 7, 2025non-GAAP EPSFY2025$2.40 – $2.48Lowered
May 7, 2025revenuesFY2025$3.48B – $3.55BRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Bruker filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. News
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?